ArticleTravel medicine and infectious disease
COVID-19 home monitoring program: Healthcare innovation in developing, maintaining, and impacting the outcome of SARS-CoV-2 infected patients.
Article in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.
- Ten pressure points in primary care during COVID-19: findings from an international narrative review.BMC primary care · 2025Pooled it
- LLM-Mediated Smart Tele-Primary Care for Rural Older Adults: A Caregiver-Centered and Scenario-Assessed Framework for Respiratory Infection Monitoring.Sensors (Basel, Switzerland) · 2026Article
- How Dutch initiatives to early discharge COVID-19 patients were organised during the pandemic: a scoping review.BMJ open · 2025Article
- Acute remote home monitoring of acutely ill patients with COVID-19: how Dutch home monitoring initiatives were organized during the pandemic.BMC health services research · 2024Article
- Review
- Characteristics and outcomes of COVID-19 home monitoring in Saudi Arabia during the second and third waves.IJID regions · 2023Article
- Risk factors associated with indoor transmission during home quarantine of COVID-19 patients.Frontiers in public health · 2023Article
- What are COVID-19 Patient Preferences for and Experiences with Virtual Care? Findings From a Scoping Review.Journal of patient experience · 2023Article
- Effectiveness of a monitored home isolation program for COVID-19 infection during the second wave of the pandemic.Medical journal, Armed Forces India · 2022Article
- Stroke Incidence and Outcome in a Population With COVID-19.The Neurohospitalist · 2022Article
- A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi Arabia.Infection and drug resistance · 2022Article
- Article
- Outcomes of home-isolated coronavirus disease 2019 patients in Bahrain.Journal of family & community medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) had caused an increased burden on healthcare organizations. Thus, a new strategy is needed to ensure all COVID-19 positive cases appropriately followed up , to receive the proper medical and psychological support, and to comply with the isolation guidelines. Here, we describe the characteristics and outcome of COVID-19 patients who were managed at home. In addition, we describe the differences between asymptomatic and those with mild symptoms. MATERIALS AND
methodsThis is descriptive study of all COVID-19 positive cases who were monitored utilizing the home care concept.
resultsDuring the study period from June 8 to October 18, 2020, there was a total of 5368 COVID-19 patients who were referred to the home isolation/monitoring program. Of those, 2397 (45%) were female and 2971 (55%) were male. Of the total cases, 295 (5%) required hospital admission, 45 (1%) were admitted to zone 2 (an intermediate care facility), and the majority 5028 (94%) were continued in the home monitoring program till recovery. Of the total cases, 3137 (59%) were asymptomatic and the remaining 41% were symptomatic. Asymptomatic patients in comparison to symptomatic patients showed significant differences in relation to mean age (+ SD) of 31.5 (+ 18.6) and 46.45 (+ 17.1), respectively (P < 0.001)), gender, being healthcare workers, and the presence of significant medical conditions. However, a logistic regression analysis showed that only age and the presence of diabetes mellitus were associated with the presence of symptoms. The mean age (±SD) of those who required hospital admission was higher than those who were continued in home monitoring or cared for in zone 2.
conclusionThe utilization of home monitoring program was effective and safe in patients who were either asymptomatic or had mild symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.